Pharmaceutical group

Tillotts

25 medicines5 countries

A group of 5 companies with 25 medicines in 5 countries.

Its medicines

Group structure

5 companies in 3 countries

Germany2

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

25 medicines

Medicine	Substance	Country	Status	Authorised
ASACOL 1.600 MG COMPRIMIDOS GASTRORRESISTENTES1.600 mg · Comprimido gastrorresistente	Mesalazine	Spain	Marketed	2021
ASACOL 1 G SUPOSITORIOS1 g · Supositorio	Mesalazine	Spain	Marketed	2021
ASACOL 400 mg COMPRIMIDOS GASTRORRESISTENTES400 mg · Comprimido gastrorresistente	Mesalazine	Spain	Marketed	1988
ASACOL 800 MG COMPRIMIDOS GASTRORRESISTENTES800 mg · Comprimido gastrorresistente	Mesalazine	Spain	Marketed	2014
BUDESONIDE3 mg · Capsule (Sustained-Release)	Budesonide	Canada	Not marketed	2020
COLPERMIN 187 MG CAPSULAS DURAS GASTRORRESISTENTES187 mg · Cápsula dura gastrorresistente	Menta piperita, aceite esencial	Spain	Marketed	2018
Dificlir	Fidaxomicin	EU (EMA)	Authorised	2011
DIFICLIRCompressa rivestita con film	Fidaxomicin	Italy	Authorised
DIFICLIR 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA200 mg · Comprimido recubierto con película	Fidaxomicin	Spain	Marketed	2012
Dificlir, 200mg, filmomhulde tablettenFilmomhulde tablet	Fidaxomicin	Netherlands	Authorised	2011
Dificlir 40 mg/ml, granulaat voor orale suspensieGranulaat voor orale suspensie	Fidaxomicin	Netherlands	Authorised	2020
DIFICLIR 40 MG/ML GRANULADO PARA SUSPENSION ORAL4,4 g · Granulado para suspensión oral	Fidaxomicin	Spain	Marketed	2020
ENTOCIRCapsula rigida a rilascio modificato	Budesonide	Italy	Authorised
ENTOCORD 2 MG COMPRIMIDO Y DISOLVENTE PARA SUSPENSION RECTAL2,3 mg · Comprimido y disolvente para suspensión rectal	Budesonide	Spain	Marketed	1998
ENTOCORD 3 mg CAPSULAS DE LIBERACION MODIFICADA3 mg · Cápsula dura de liberación modificada	Budesonide	Spain	Marketed	1997
ENTOCORT3 mg · Capsule (Sustained-Release)	Budesonide	Canada	Marketed	1997
Entocort capsules 3 mg, capsules met gereguleerde afgifteCapsule met verlengde afgifte, hard	Budesonide	Netherlands	Authorised	1996
ENTOCORT ENEMA2.3 mg · Enema, Kit, Tablet	Budesonide	Canada	Marketed	1994
Entocort Klysma, suspensie voor rectaal gebruik 2 mg/100 mlSuspensie voor rectaal gebruik	Budesonide	Netherlands	Authorised	1993
Kiudro 1 g zetpilZetpil	Mesalazine	Netherlands	Authorised	2021
MESALAMINE800 mg · Tablet (Delayed-Release)	Mesalazine	Canada	Authorised
OCTASA1600 mg · Tablet (Delayed-Release)	Mesalazine	Canada	Marketed	2023
OCTASA800 mg · Tablet (Delayed-Release)	Mesalazine	Canada	Marketed	2022
Yaldigo 1600 mg, tabletten met gereguleerde afgifteTablet met gereguleerde afgifte	Mesalazine	Netherlands	Authorised	2018
COLPERMIN ENTERIC COATED CAP 187MG187 mg · Capsule (Enteric-Coated)	Peppermint oil	Canada	Cancelled	1992

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	9	9	0	Companies All medicines
Canada	7	6	1	Companies All medicines
Netherlands	6	6	0	Companies All medicines
Italy	2	2	0	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 15 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Report an error or request removalCorrections from the company itself are welcome.

Tillotts

Group structure

Germany2

Spain1

United Kingdom1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Group structure

🇩🇪Germany2

🇪🇸Spain1

🇬🇧United Kingdom1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Germany2

Spain1

United Kingdom1